Skip to main content
Premium Trial:

Request an Annual Quote

ReliaGene to Market DNAPrint s Genetic Test to Law Enforcement Agencies

NEW YORK, July 13 (GenomeWeb News) - DNAPrint Genomics said today that DNA testing firm ReliaGene Technologies will distribute its DNAWitness 2.5 genetic testing technology to law enforcement agencies worldwide.


DNAPrint said that its technology is well suited to forensic analysis because it can be used to infer physical characteristics based on DNA sequence gleaned from evidence samples. Under the terms of the agreement, New Orleans-based ReliaGene will send forensic samples for certain criminal cases for which there is no suspect to DNAPrint for analysis.


ReliaGene, founded in 1990, markets the Y-Plex genotyping system.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.